Ironwood Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 22.92 M | $94.43 M | 100.00% | 14.35% |
VANGUARD GROUP INC | 11/13/2024 | 22.04 M | $90.80 M | 2.20% | 13.80% |
SARISSA CAPITAL MANAGEMENT LP | 11/14/2024 | 16.39 M | $67.53 B | 0.00% | 10.26% |
PACER ADVISORS, INC. | 11/12/2024 | 11.28 M | $46.47 M | 26.63% | 7.06% |
UBS GROUP AG | 11/14/2024 | 11.20 M | $46.15 M | 0.00% | 7.01% |
STATE STREET CORP | 11/14/2024 | 9.92 M | $40.87 M | 7.32% | 6.21% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 8.60 M | $35.42 M | 0.30% | 5.38% |
ARMISTICE CAPITAL, LLC | 11/14/2024 | 8.20 M | $33.78 M | 5.13% | 5.13% |
LSV ASSET MANAGEMENT | 11/12/2024 | 5.05 M | $20.81 M | -16.80% | 3.16% |
BRAIDWELL LP | 11/14/2024 | 4.44 M | $18.29 M | 0.00% | 2.78% |
MORGAN STANLEY | 11/14/2024 | 4.32 M | $17.80 M | -11.09% | 2.71% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 4.27 M | $17.57 M | -2.14% | 2.67% |
KYNAM CAPITAL MANAGEMENT, LP | 11/14/2024 | 3.69 M | $15.18 M | 124.47% | 2.31% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 3.29 M | $13.57 M | -2.34% | 2.06% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 1.90 M | $7.85 M | 23.70% | 1.19% |
JUPITER ASSET MANAGEMENT LTD | 11/12/2024 | 1.45 M | $5.97 M | 0.00% | 0.91% |
TWO SIGMA ADVISERS, LP | 11/14/2024 | 1.26 M | $5.19 M | 5.13% | 0.79% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.22 M | $5.04 M | -21.77% | 0.77% |
SATURN V CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.12 M | $4.62 M | 0.59% | 0.70% |
STONEPINE CAPITAL MANAGEMENT, LLC | 11/13/2024 | 1.00 M | $4.12 M | 1,982.81% | 0.63% |
UBS GROUP AG | 11/14/2024 | 946,884 | $3.90 M | -48.53% | 0.59% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 925,872 | $3.81 M | -30.32% | 0.58% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 912,778 | $3.76 M | -12.52% | 0.57% |
MAN GROUP PLC | 11/14/2024 | 894,726 | $3.69 M | -70.02% | 0.56% |
TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 890,963 | $3.67 M | -2.90% | 0.56% |
ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 786,292 | $3.24 M | 100.00% | 0.49% |
PRINCIPAL FINANCIAL GROUP INC | 10/31/2024 | 735,727 | $3.03 M | -7.49% | 0.46% |
CITADEL ADVISORS LLC | 11/14/2024 | 697,426 | $2.87 M | 70.30% | 0.44% |
ROYCE & ASSOCIATES LP | 11/06/2024 | 662,934 | $2.73 M | 10.75% | 0.42% |
AMERIPRISE FINANCIAL INC | 11/14/2024 | 598,202 | $2.46 M | -6.29% | 0.37% |
CAPITAL FUND MANAGEMENT S.A. | 11/13/2024 | 581,359 | $2.40 M | 90.22% | 0.36% |
STATE OF WISCONSIN INVESTMENT BOARD | 11/14/2024 | 573,426 | $2.36 M | 226.62% | 0.36% |
QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 570,775 | $2.35 M | 100.00% | 0.36% |
AQR CAPITAL MANAGEMENT LLC | 11/14/2024 | 564,113 | $2.32 M | -17.60% | 0.35% |
REDWOOD INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 534,560 | $2.15 M | 12.36% | 0.33% |
INVESCO LTD. | 11/12/2024 | 527,694 | $2.17 M | -68.34% | 0.33% |
RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 463,047 | $1.91 M | -16.52% | 0.29% |
EMERALD ADVISERS, LLC | 10/29/2024 | 456,770 | $1.88 M | -41.91% | 0.29% |
PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 455,477 | $1.88 M | -48.02% | 0.29% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 419,773 | $1.73 M | -41.08% | 0.26% |
LEGAL & GENERAL GROUP PLC | 11/14/2024 | 419,482 | $1.73 M | -0.08% | 0.26% |
BARCLAYS PLC | 11/19/2024 | 416,320 | $1.72 M | 111.31% | 0.26% |
SEI INVESTMENTS CO | 11/12/2024 | 410,680 | $1.69 M | 100.00% | 0.26% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 405,354 | $1.67 M | -11.77% | 0.25% |
RAFFERTY ASSET MANAGEMENT, LLC | 11/13/2024 | 396,664 | $1.63 M | 3.20% | 0.25% |
ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. | 10/29/2024 | 380,960 | $1.57 M | 1,293.62% | 0.24% |
GSA CAPITAL PARTNERS LLP | 11/05/2024 | 351,193 | $1.45 M | 194.86% | 0.22% |
HODGES CAPITAL MANAGEMENT INC. | 11/15/2024 | 347,500 | $1.43 M | -66.62% | 0.22% |
RHUMBLINE ADVISERS | 11/12/2024 | 337,965 | $1.39 M | -7.58% | 0.21% |
JANE STREET GROUP, LLC | 11/15/2024 | 323,638 | $1.33 M | 102.74% | 0.20% |
Ironwood Pharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 328 institutional investors and hedge funds held shares of Ironwood Pharmaceuticals, Inc.. The most heavily invested institutionals were:
EVERENCE CAPITAL MANAGEMENT INC: 0
City State Bank: 0
GAMMA Investing LLC: 0
BlackRock Funding, Inc. /DE: 22.92 M
VANGUARD GROUP INC: 22.04 M
Sarissa Capital Management LP: 16.39 M
102.12% of Ironwood Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 209.85 M shares in the last 24 months. This purchase volume represents approximately $765.97 M in transactions.